Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) requires lengthy use of second-line drugs, burdened by many side effects. Hepatitis C virus (HCV) chronic infection increases risk of drug-induced liver injury (DILI) in these patients. Data on MDR-TB patients with concurrent HCV chronic infectio...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Infect Dis
Glavni autori: Musso, Maria, Mosti, Silvia, Gualano, Gina, Mencarini, Paola, Urso, Rocco, Ghirga, Piero, Rianda, Alessia, Del Nonno, Franca, Goletti, Delia, Palmieri, Fabrizio
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6806539/
https://ncbi.nlm.nih.gov/pubmed/31640579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-4494-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items